Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

"Och Aye" - Oh Yes
"The Noo" - Now

How's that? Spell checkers be damned.

Thanks Arf,

Knew someone would put me right. Clever ***.
At least I am better at picking shares (not by much) than I am at spelling.

Charles Stanley reiterated its "Buy" stance for Deltex Medical (DEMG), citing the potential for revenue growth of 40% for the three years to 2009 and the company's plausible attraction as a takeover target. However, its shares shed 0.75p to 27.5p.

Still out of favor with the market, but I think the Charles Stanley projection is on the conservative side.

Yet another report on the benefits of CardioQ.
2517

Yes as you say yet another, although you can't really have too many, but how many more are required before the NHS mis-managers get their very dim fingers out and buy the b****y thing. They remind me of those three monkeys, hear nowt, say nowt, see nowt,( yes I know it was a bit of poetic license).

Still think the first real big NHS contract will come this year, which will start the ball rolling.

There has to be plenty in the pipeline, due to the extra capacity, Deltex are gearing up to.

greekman -------- With DEMG gearing up to cope with demand ahead of that demand, I believe it shows the forward thinking management are in front of the curve, and that DEMG will be ready for the increase in capacity as it materialises, as it surely will.
2517

Trading update looks promising. Sales well on track and steadily increasing. The next 6/12 months look to have even more potential.

I was sitting out in the sun reading the newspaper, when the news from Deltex came in re pre-close update on the six months ended 30 June 2007, now that news was first class, much better than the newspaper. Establishing the use of the Cardio system, US market increased by approximately half since the start of the year. At shareclubuk.co.uk the out-of -town members are saying that DEMG has the right product sales now to soon be into profits. Both UK and US sales are up, this on its own must be a step in the right direction.

Myway,

Sorry to go off subject, but "sitting out in the sun". Where, when?

Looks like an '04 repeat..... Lets see if the sp can break 34p with this climb...!

Nice piece in shares today.
2517

RNS,

Recommendation for CardioQ,

The Planned Care Clinical Working Group was established to report into the
Healthcare for London Review. This review was led by Sir Ara Darzi, who was
recently appointed a minister at the Department of Health, with responsibility
for conducting the national NHS Next Stage review.

Sir Darzi did not waste much time compiling this very intensive report.
I have looked through it but did not see the CardioQ referred to by name, just the increased use of oesophageal Doppler monitoring. As the CardioQ has been the most successful in test concluded in London Hospitals it obviously (I hope) refers to the CardioQ by inference.

Lets just hope the Government take note. (See my post 459 first referring to Sir Darzi).
.

I believe it's just a matter of time, hopefully not too much though. The 30.45p deals are buys.
2517

This is rather disappointing.
2517

Another chance for Deltex to push the CardioQ.

Innovative MedTech Companies Selected to Present to Collaborators, Strategic Partners, and Investors at AdvaMed 2007


http://sev.prnewswire.com/health-care-hospitals/20070823/DCTH00823082007-1.html

How many more chances does this company need, maybe if everyone got behind and pushed............. Agreed budding business and great model but you gotta question the management and not the NHS over flat sales...

explosive--------It takes time to build up sales, I am as disappointed as yourself especially as the sp has retreated from 31p since the end of july. I would not be too quick to blame the management though.
2517

Results.

No real surprises. It's steady as she goes. Still awaiting that big order jump, although nice to see the USA increasingly in on the act.
The only thing that bothers me is the cash situation. Although cash burn is reducing, the cushion is a bit low for comfort. In total I feel we need as much patience as the Deltex management appear to have.
Looks like a HOLD.

greekman I agree-----------Patience and Patients required for DEMG the sp is a far cry from the 31p a few months ago, sales are increasing and the 2H is stonger than the 1H, whereas more than half the annual admin costs were in the 1H which should reduce the cash burn. Still looks promising, but time is required. I did sell part of my holding @ 27.75p and have bought back in again since, whether I want any more I'm not sure. I like IPX atm so may have a look there. Good look all.
2517

The drop is today is due to 2 reasons. The market in general, but mainly because punters patience is wearing a bit thin.
Deltex management appear to be doing their best, with presentations, sales pitches and publishing the now 50 plus positive trial results.
Can't see that they and us can do any more but wait, and hope the powers that be see the light before the money runs out.
The managerial cogs in the medical field appear to turn ever slower.
Perhaps the decision makers, especially in the NHS should have an operational procedure termed, extract-um digit-um from anusectomy.